Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leiomyoma × Embolization, Therapeutic × Clear all

Phase

Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 3 Carcinoma, Hepatocellular 3 Liver Neoplasms 2 Uveal Melanoma 1 Rectal Neoplasms 1 Pelvic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Leiomyoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Chylous Ascites 1 Abdominal Neoplasms 1

Interventions

telapristone acetate 10 ulipristal 3 vilaprisan 2 Mifepristone 2 Leuprolide 2 ulipristal acetate 1 relugolix 1 pirfenidone 1 estradiol, norethindrone drug combination 1 epigallocatechin gallate 1 elagolix 1 asoprisnil 1 Tea 1 Sugars 1 Norethindrone Acetate 1 Morphine 1 Methadone 1 Lidocaine 1 Estradiol 1 Embolization, Therapeutic 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00839722 2019-06-20

EFU

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡